EVIDENCE LIBRARY
Why Were Nitazenes Expected in Only Three Drug-Checking Submissions?
Short answer: The Canadian study reported that nitazenes were expected in only three of 532 nitazene-positive drug-checking submissions. “Expected” described what was anticipated when samples were submitted. It was not a measure of how often nitazenes occur in every drug supply or proof that every unexpected result came from intentional adulteration.
What was the denominator?
Gelgoot and colleagues combined data from Toronto’s Drug Checking Service, drug-checking partners affiliated with the British Columbia Centre on Substance Use and Health Canada police-seizure analyses. Across 668,486 analyzed samples, 4,074 contained a nitazene. The 532 in the expectation finding were the nitazene-positive drug-checking samples: 489 from Toronto and 43 from British Columbia. Police-seizure samples were a separate stream and should not be silently added to that denominator.
What does “expected” mean?
A submitted sample may be described as fentanyl, “down,” another drug or an unknown substance before laboratory analysis. Only three of the 532 nitazene-positive drug-checking samples were expected to contain a nitazene. This mismatch shows why a submitter’s label is not chemical identification. It does not tell us how accurately every submitter recognized the source, or whether they knew an analogue was present.
How should this be used?
For a particular sample, review the actual analytical report, the tested analytes and method, confirmatory analysis, reporting thresholds and any co-detected substances. Novel compounds can be missed if a method or reference library does not cover them. A result from one service or period cannot establish the content of another sample at another place and time.
The authors state that submitted drug-checking and seizure samples do not fully represent the Canadian unregulated market. The finding supports testing over assumptions about identity; it is not a population prevalence estimate or a claim that nitazenes caused every associated overdose.
Scientific source
Gelgoot EA, Scarfone KM, Maghsoudi N, et al. The Detection of Novel Nitazene-Class Opioids in Unregulated Drug Markets in Canada. Drug and Alcohol Review. 2026;45:e70189. doi:10.1111/dar.70189. Based on the supplied full paper.